MetaVia
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
CEOHyung-Heon Kim
CEOHyung-Heon Kim
Employees9
Employees9
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees9
Employees9
MTVA Key Statistics
Market cap16.97M
Market cap16.97M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume49.22K
Average volume49.22K
High today$0.70
High today$0.70
Low today$0.6838
Low today$0.6838
Open price$0.6977
Open price$0.6977
Volume28.52K
Volume28.52K
52 Week high$3.82
52 Week high$3.82
52 Week low$0.5555
52 Week low$0.5555
People also own
Based on the portfolios of people who own MTVA. This list is generated using Robinhood data, and it’s not a recommendation.